Literature DB >> 9780059

Differences in the intracellular localization and fate of herpes simplex virus tegument proteins early in the infection of Vero cells.

E E Morrison1, A J Stevenson, Y F Wang, D M Meredith.   

Abstract

The fate of herpes simplex virus 1 (HSV-1) tegument proteins during infection in Vero cells was investigated immunochemically. Input virion-associated VP13/14 and VP16 localized to the nucleus early in infection, while VP1/2 localized to the nuclear envelope of the cell and VP22 could not be detected using monoclonal antibody P43. Western blotting suggested that virion-associated VP13/14, VP16 and VP22 were stable in infected cells whereas VP1/2 appeared to be processed or modified. Further studies showed that P43 recognized a phosphorylation-sensitive epitope in VP22 and suggested that virion-associated VP22 was phosphorylated upon entry to the cell. VP13/14 and VP16 were easily extracted from cells early in infection whereas VP22 was largely insoluble. Phosphatase treatment of soluble extracts caused a shift in the molecular mass of VP16 showing it was phosphorylated. As infection progressed VP16 was observed in discrete nuclear compartments where it co-localized with ICP8 and the capsid-associated protein VP22a. VP13/14 was also observed in the nucleus. P43 immunostaining appeared around 6 h post-infection as punctate nuclear foci which often localized to the edge of VP16-immunoreactive areas. Punctate P43 cytoplasmic staining appeared around 12 h post-infection. By 18 h the nuclear pattern had disappeared and an extensive cytoplasmic stain was observed which closely overlapped that of other tegument proteins. On the basis of these data we suggest that virion-associated VP22 is phosphorylated upon entry of the virus into the cell and that unphosphorylated VP22, which is preferentially recognized by P43, becomes available later in infection, initially in the nucleus, for packaging into virions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780059     DOI: 10.1099/0022-1317-79-10-2517

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  48 in total

1.  Cytoplasm-to-nucleus translocation of a herpesvirus tegument protein during cell division.

Authors:  G Elliott; P O'Hare
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Nuclear localization and shuttling of herpes simplex virus tegument protein VP13/14.

Authors:  M Donnelly; G Elliott
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  A null mutation in the UL36 gene of herpes simplex virus type 1 results in accumulation of unenveloped DNA-filled capsids in the cytoplasm of infected cells.

Authors:  P J Desai
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  The role of the cytoskeleton in the life cycle of viruses and intracellular bacteria: tracks, motors, and polymerization machines.

Authors:  E L Bearer; P Satpute-Krishnan
Journal:  Curr Drug Targets Infect Disord       Date:  2002-09

5.  In rat dorsal root ganglion neurons, herpes simplex virus type 1 tegument forms in the cytoplasm of the cell body.

Authors:  Monica Miranda-Saksena; Ross A Boadle; Patricia Armati; Anthony L Cunningham
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Sequential localization of two herpes simplex virus tegument proteins to punctate nuclear dots adjacent to ICP0 domains.

Authors:  Ian Hutchinson; Alison Whiteley; Helena Browne; Gillian Elliott
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Analysis of HCF, the cellular cofactor of VP16, in herpes simplex virus-infected cells.

Authors:  S LaBoissière; P O'Hare
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations.

Authors:  J S Harms; X Ren; S C Oliveira; G A Splitter
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Characterization of VP22 in herpes simplex virus-infected cells.

Authors:  G Mouzakitis; John McLauchlan; Cristina Barreca; Lisa Kueltzo; P O'Hare
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

10.  Interaction of HCF-1 with a cellular nuclear export factor.

Authors:  Shahana S Mahajan; Markus M Little; Rafael Vazquez; Angus C Wilson
Journal:  J Biol Chem       Date:  2002-09-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.